Topics in Clinical Biosecurity: Anthrax
              

Listed below are all CBN* articles on Anthrax published since 2005

• 04/13/2012. The Effect of Anti-lethal Toxin Antibodies on Anthrax Mortality: Results of a recent study suggest that treatment with antitoxin antibodies may be effective for all cases of anthrax that progress to septic shock. If results are validated for humans, then a robust supply of these products will be needed for the SNS. 
• 02/17/2012. Genetic Susceptibility to Anthrax: A new study suggests that susceptibility to anthrax toxins may be genetic and variable. The results shed light on the relationship between anthrax toxins and human cell receptors, with potential implications for next generation countermeasure development. 
• 09/02/2011. Anthrax-like Disease Caused by Bacillus cereus: A man in Texas recently died of an anthrax-like illness that was caused by a toxin-producing strain of B. cereus. Of the Bacillus species known to cause human disease, only B. anthracis is generally recognized as capable of causing fulminant disease. 
• Hundreds of Cutaneous Anthrax Cases in Bangladesh. September 15, 2010. 
• Anthrax Cases Among Heroin Users in Europe Illustrate Novel Risk. January 21, 2010. 
• Unusual Case of GI Anthrax in New Hampshire Raises Questions. January 7, 2010. 
• CDC Publishes Report on Meeting of Experts to Update Guidelines for Management of Anthrax. April 14, 2008. 
• The Use of MedKits to Augment Rapid Distribution of Antibiotics after an Anthrax Attack. March 14, 2008. 
• HHS Award Multiple Contracts for Anthrax Countermeasures. September 28, 2007. 
• Symptoms of Anthrax in Children May be More Varied than Previously Thought. September 14, 2007. 
• Partial Anthrax Vaccination Stimulates Significant Antibody Response. January 26, 2007. 
• Immunological Responses after Exposure to Anthrax Spores in the U.S. Capitol, 2001. January 18, 2007. 
• New Anthrax Countermeasure to be Acquired by HHS. July 20, 2006. 
• Safety and Immunogenicity of the Second Generation Anthrax Vaccine Candidate. June 16, 2006. 
• Could the Duration of Postexposure Antibiotic Prophylaxis Against Inhalational Anthrax be Shortened? March 17, 2006. 
• Isolated Case of Naturally-Occurring Inhalational Anthrax in a New York City Resident. February 23, 2006. 
• Potential Anthrax Therapeutic. July 11, 2005. 
• Disease Reporting Rules; Anthrax Anti-toxin. June 6, 2005. 
• Anthrax Meningitis. May 9, 2005. 
• Anthrax Response; New Vaccines. April 26, 2005. 

                         
*Formerly The Clinicians' Biosecurity Network Report; title changed in July 2011